Large COVID-19 study finds no meaningful benefit of ivermectin vs. placebo in Brazil

A large, randomized study in Brazil found that COVID-19 patients who received ivermectin, an anti-parasite medicine that surged in popularity as a potential treatment for the coronavirus, did not meaningfully reduce the risk of hospitalization.

The study included more than 3,500 who were randomly assigned to ivermectin (679 patients), placebo ...